Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America

Epidermal Growth Factor Receptor (EGFR) exon 19-deletion and exon 21 L858R mutation is found in 10% of Non-Small Cell Lung Carcinoma (NSCLC) in Caucasians and in 20 to 40% in Asians. The use of Tyrosine Kinase Inhibitors (TKI) in these genetic alterations has demonstrated a greater response and prog...

Full description

Autores:
Fernández, Liliana
Tipo de recurso:
http://purl.org/coar/resource_type/c_c94f
Fecha de publicación:
2016
Institución:
Universidad ICESI
Repositorio:
Repositorio ICESI
Idioma:
eng
OAI Identifier:
oai:repository.icesi.edu.co:10906/81356
Acceso en línea:
http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2589
http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=7&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1
http://hdl.handle.net/10906/81356
Palabra clave:
Ciencias socio biomédicas
Medical sciences
Pulmonar
Carcinoma
Crecimiento epidérmico
Fundación Valle del Lili
Rights
openAccess
License
https://creativecommons.org/licenses/by-nc-nd/4.0/
id ICESI2_1c70d4bff95177ec4e80a6f52471f99f
oai_identifier_str oai:repository.icesi.edu.co:10906/81356
network_acronym_str ICESI2
network_name_str Repositorio ICESI
repository_id_str
spelling Fernández, Lilianalilianafernandeztrujillo@gmail.comNew York de Lat: 40 42 00 N degrees minutes Lat: 40.7000 decimal degrees Long: 074 00 00 W degrees minutes Long: -74.0000 decimal degrees2017-04-25T21:25:30Z2017-04-25T21:25:30Z2016-01-010041-0101http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2589http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=7&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1http://hdl.handle.net/10906/81356instname: Universidad Icesireponame: Biblioteca Digitalrepourl: https://repository.icesi.edu.co/Epidermal Growth Factor Receptor (EGFR) exon 19-deletion and exon 21 L858R mutation is found in 10% of Non-Small Cell Lung Carcinoma (NSCLC) in Caucasians and in 20 to 40% in Asians. The use of Tyrosine Kinase Inhibitors (TKI) in these genetic alterations has demonstrated a greater response and progression free survival in 9-15 months. Objective: To describe the experience in EGFR identification in Fundación Valle del Lili (FVL). Materials and Methods Between June/2013 and Sep/2015, 95 samples were analyzed. A microdissection of tumor areas was performed as well as DNA extraction with QIAamp FFPE Kit(Qiagen®) and amplification of exons 18, 19, 20 and 21 by PCR. It was visualized through microfluidic electrophoresis with Agilent Bioanalyzer® System. Results 98 samples were analyzed. Amplified DNA was obtained in 97% (95) of the cases. The mean age was 65,4±12 years, 63,2% (60) females and 36,8% (35) males. The mutation was observed in 25% (24), exon 19 in 10,5% and exon 21 in 14,7%. 83,1% of the tumors were adenocarcinomas, 70,5% in stage IV and 29% of the cases with a mutation was receiving TKI. Mortality was 14,7% .1 páginaDigitalapplication/pdfengAmerican Lung AssociationElsevierFacultad Ciencias de la SaludMedicinaDepartamento de Ciencias Básicas MédicasNew YorkAmerican Journal of Respiratory and Critical Care Medicine, Vol: 193 - 2016EL AUTOR, expresa que la obra objeto de la presente autorización es original y la elaboró sin quebrantar ni suplantar los derechos de autor de terceros, y de tal forma, la obra es de su exclusiva autoría y tiene la titularidad sobre éste. PARÁGRAFO: en caso de queja o acción por parte de un tercero referente a los derechos de autor sobre el artículo, folleto o libro en cuestión, EL AUTOR, asumirá la responsabilidad total, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos, la Universidad Icesi actúa como un tercero de buena fe. Esta autorización, permite a la Universidad Icesi, de forma indefinida, para que en los términos establecidos en la Ley 23 de 1982, la Ley 44 de 1993, leyes y jurisprudencia vigente al respecto, haga publicación de este con fines educativos. Toda persona que consulte ya sea la biblioteca o en medio electrónico podrá copiar apartes del texto citando siempre la fuentes, es decir el título del trabajo y el autor.https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessAtribuci�n-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)http://purl.org/coar/access_right/c_abf2Ciencias socio biomédicasMedical sciencesPulmonarCarcinomaCrecimiento epidérmicoFundación Valle del LiliEpidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin Americainfo:eu-repo/semantics/conferenceObjecthttp://purl.org/coar/resource_type/c_c94fDocumento de conferenciainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Comunidad Universidad Icesi – Investigadores193A2589A2589ORIGINALdocumento.htmldocumento.htmltext/html399http://repository.icesi.edu.co/biblioteca_digital/bitstream/10906/81356/1/documento.html4301a40bddaacfedddadcb5f7319ace9MD5110906/81356oai:repository.icesi.edu.co:10906/813562018-11-16 10:09:14.633Biblioteca Digital - Universidad icesicdcriollo@icesi.edu.co
dc.title.spa.fl_str_mv Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
title Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
spellingShingle Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
Ciencias socio biomédicas
Medical sciences
Pulmonar
Carcinoma
Crecimiento epidérmico
Fundación Valle del Lili
title_short Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
title_full Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
title_fullStr Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
title_full_unstemmed Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
title_sort Epidermal Growth Factor Receptor Mutation In Patients With Non-Small Cell Lung Carcinoma In Fundacion Valle Del Lili, A University Hospital Of Reference In Latin America
dc.creator.fl_str_mv Fernández, Liliana
dc.contributor.author.spa.fl_str_mv Fernández, Liliana
dc.subject.none.fl_str_mv Ciencias socio biomédicas
Medical sciences
Pulmonar
Carcinoma
Crecimiento epidérmico
topic Ciencias socio biomédicas
Medical sciences
Pulmonar
Carcinoma
Crecimiento epidérmico
Fundación Valle del Lili
dc.subject.spa.fl_str_mv Fundación Valle del Lili
description Epidermal Growth Factor Receptor (EGFR) exon 19-deletion and exon 21 L858R mutation is found in 10% of Non-Small Cell Lung Carcinoma (NSCLC) in Caucasians and in 20 to 40% in Asians. The use of Tyrosine Kinase Inhibitors (TKI) in these genetic alterations has demonstrated a greater response and progression free survival in 9-15 months. Objective: To describe the experience in EGFR identification in Fundación Valle del Lili (FVL). Materials and Methods Between June/2013 and Sep/2015, 95 samples were analyzed. A microdissection of tumor areas was performed as well as DNA extraction with QIAamp FFPE Kit(Qiagen®) and amplification of exons 18, 19, 20 and 21 by PCR. It was visualized through microfluidic electrophoresis with Agilent Bioanalyzer® System. Results 98 samples were analyzed. Amplified DNA was obtained in 97% (95) of the cases. The mean age was 65,4±12 years, 63,2% (60) females and 36,8% (35) males. The mutation was observed in 25% (24), exon 19 in 10,5% and exon 21 in 14,7%. 83,1% of the tumors were adenocarcinomas, 70,5% in stage IV and 29% of the cases with a mutation was receiving TKI. Mortality was 14,7% .
publishDate 2016
dc.date.issued.none.fl_str_mv 2016-01-01
dc.date.accessioned.none.fl_str_mv 2017-04-25T21:25:30Z
dc.date.available.none.fl_str_mv 2017-04-25T21:25:30Z
dc.type.eng.fl_str_mv info:eu-repo/semantics/conferenceObject
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_c94f
dc.type.local.spa.fl_str_mv Documento de conferencia
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_c94f
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 0041-0101
dc.identifier.other.spa.fl_str_mv http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2589
http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=7&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10906/81356
dc.identifier.instname.none.fl_str_mv instname: Universidad Icesi
dc.identifier.reponame.none.fl_str_mv reponame: Biblioteca Digital
dc.identifier.repourl.none.fl_str_mv repourl: https://repository.icesi.edu.co/
identifier_str_mv 0041-0101
instname: Universidad Icesi
reponame: Biblioteca Digital
repourl: https://repository.icesi.edu.co/
url http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A2589
http://nebulosa.icesi.edu.co:2143/full_record.do?product=WOS&search_mode=GeneralSearch&qid=7&SID=3Dr7QVLgmeqIWKgWekv&page=1&doc=1
http://hdl.handle.net/10906/81356
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv American Journal of Respiratory and Critical Care Medicine, Vol: 193 - 2016
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.license.none.fl_str_mv Atribuci�n-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
Atribuci�n-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.none.fl_str_mv 1 página
dc.format.medium.spa.fl_str_mv Digital
dc.format.mimetype.none.fl_str_mv application/pdf
dc.coverage.spatial.none.fl_str_mv New York de Lat: 40 42 00 N degrees minutes Lat: 40.7000 decimal degrees Long: 074 00 00 W degrees minutes Long: -74.0000 decimal degrees
dc.publisher.spa.fl_str_mv American Lung Association
dc.publisher.none.fl_str_mv Elsevier
dc.publisher.faculty.spa.fl_str_mv Facultad Ciencias de la Salud
dc.publisher.program.spa.fl_str_mv Medicina
dc.publisher.department.spa.fl_str_mv Departamento de Ciencias Básicas Médicas
dc.publisher.place.none.fl_str_mv New York
publisher.none.fl_str_mv Elsevier
institution Universidad ICESI
bitstream.url.fl_str_mv http://repository.icesi.edu.co/biblioteca_digital/bitstream/10906/81356/1/documento.html
bitstream.checksum.fl_str_mv 4301a40bddaacfedddadcb5f7319ace9
bitstream.checksumAlgorithm.fl_str_mv MD5
repository.name.fl_str_mv Biblioteca Digital - Universidad icesi
repository.mail.fl_str_mv cdcriollo@icesi.edu.co
_version_ 1808499120159064064